Tim Lenihan joins CV Lab’s Board of Directors

Cardiovascular Lab (CVLab) is delighted to announce that Tim Lenihan has accepted to join its Board of Directors. With his long-term experience in nurturing early-stage medical device projects, Tim will strengthen CVLab’s ability to support disruptive projects in the cardiovascular field.

A serial entrepreneur with over 30 years of experience in the medical device field in a variety of disciplines, in 2009 Tim Lenihan co-founded MD Start, the French early-stage medical device incubator, together with Sofinnova Partners and the medtech serial entrepreneur Gerard Hascoet, later partners including Medtronic and Sorin Group, where he helped create and fund 7 companies. Prior to founding MD Start, Tim was CEO and Founder of Contract Medical International GmbH (CMI) a contract developer and manufacturer of catheter-based medical devices. He is currently the CTO & Board Chair of Precardia and board member of LimFlow and Spinal Singularity. Tim holds a bachelor’s degree in biomedical engineering from Rensselaer Polytechnic Institute and a master’s degree from the University of Pennsylvania.

«I’m excited to join CV Lab and to work with the team of serial entrepreneurs and innovators to help realize their products.  I look forward to helping bring their new ideas to market», said Tim Lenihan

«We are delighted to welcome Tim, who is a key figure in the European medtech innovation space. We feel very privileged to be able to leverage his vision and experience to advance medical technology, at a time when this has never been more important», commented Andrea Venturelli, Chairman of the Board of Directors.

CV Lab appoints Marta Antonucci as Ceo

Turin-Milan (Italy) – The Board of Directors of CV Lab has appointed Marta Antonucci as Ceo of the company. Antonucci is the first manager to take on the role after the foundation of the incubator and the beginning of activities in the Summer of 2016. Read more…

CV Lab in San Francisco for #JPM2017

The CV Lab Team is in San Francisco this week, attending the 35th J.P. Morgan Healthcare Conference, one of the largest events of the year in the lifesciences industry. The annual meeting brings thousands of investors and executives from around the world to San Francisco where worldwide companies present their latest innovations, hoping to find their next partner or investor. Read more…

CV Lab al Congresso annuale della Società Italiana di Cardiologia

CV Lab, il primo incubatore in Europa per progetti nel settore cardiovascolare, sarà presente al 77° Congresso nazionale della Società Italiana di Cardiologia. Nel corso dell’evento, che si terrà a Roma dal 16 al 19 dicembre, il team CV Lab incontrerà medici e ricercatori per illustrare i propri servizi nel settore dell’innovazione del settore medicale. Read more…

CV Lab, the first incubator for cardiovascular projects in Europe

Turin-Milan (Italy) – Italian cardiology school is among the most respected in the world. However only a fraction of the creativity of the Italian research is actually transformed into a product or a company. To overcome this issue, some of the leading entrepreneurs in the cardiovascular sector, together with the most important Italian investors, joined their forces to create an incubator that helps physicians and scientists Read more…